CEO Andrew Whelan of BioElectronics Corp, returns to Stock Day to discuss details of the FDA Innovation Challenge on opioid use, ActiPatch international sales, and plans for growth.

OTCPink: BIEL # 7-day trial device # Amazon # pain management # innovative # miniaturized technology # ActiPatch # Musculoskeletal Pain Relief # Allay Menstrual Pain Therapy # chronic pain relief # HealFast Therapy # Health Care # Medical Stocks # Postoperative Recovery # Chronic Wounds # RecoveryRx